News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Iframe sync Post navigation Previous: Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories EHR Healthcare News IntelePeer Agentic AI Trend Report Cites Trust, Day-One Value, Integration, and Analytics as Critical Success Factors in Healthcare Deployments Staff December 22, 2025 EHR Healthcare News IntelePeer Agentic AI Trend Report Cites Trust, Day-One Value, Integration, and Analytics as Critical Success Factors in Healthcare Deployments Staff December 22, 2025 EHR Healthcare Medicaid Medicare News Netsmart Strengthens Interoperability Leadership Through CMS Health Technology Ecosystem Pledge Staff December 22, 2025
